Biopharmaceutical

From Free net encyclopedia

The term biopharmacology also describes a field of research closely related to pharmacokinetics, sometimes called biopharmacy.

Biopharmaceuticals are medical drugs (see pharmacology) produced by biotechnology. They are actually proteins or nucleic acids (DNA and RNA) used for therapeutic or in vivo diagnostic purposes, which is produced by means other than direct extraction from a native (non-engineered) biological source.

The first such substance approved (1982) for therapeutic use was recombinant human insulin, (rHI, trade name Humulin) developed by Genentech and marketed by Eli Lily.

Image:Nrc-bri-bioprocess-lr.jpg

Contents

Classification of Biopharmaceuticals

Uses

Large scale production

Biopharmaceuticals may be produced from microbial cells (e.g. recombinant E. coli), mammalian cell lines (See Cell culture) and plant cell cultures (See Plant tissue culture) in bioreactors of various configurations.

Important issues of concern are cost of production (low volume high purity product) and microbial contamination (bacteria, virus, mycoplasma, etc). Alternative platforms of production that are being tested include whole plants (Plant-made pharmaceuticals).

See also

Reference

Template:Biotech-stub

ca:Biofarmacologia